Dosing strategies for MLN8054, a selective Aurora A kinase inhibitor, based on pharmacokinetic modeling and simulations

  1. Lee, Y.
  2. Eton, O.
  3. Pappas, J.
  4. Chen, S.
  5. Paton, M.
  6. Dees, E. C.
  7. Jones, S.
  8. Cohen, R. B.
  9. Cervantes, A.
  10. Tabernero, J.
Journal:
EJC SUPPLEMENTS

ISSN: 1359-6349

Year of publication: 2008

Volume: 6

Issue: 12

Pages: 130-131

Congress: 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Type: Conference paper

DOI: 10.1016/S1359-6349(08)72349-8 GOOGLE SCHOLAR